Summary
Updated Aug 31, 2026
BridgeBio Pharma LLC files SEC Form 4 reports at BridgeBio Oncology Therapeutics, Inc. (BBOT). 1 SEC Form 4 filing on record, dated 10 October 2025.
Recent Transactions
1Every recent SEC Form 4 transaction BridgeBio Pharma LLC has reported, most recent first.
Trading Pattern
InsiderAlpha's records for BridgeBio Pharma LLC go back to 2025: 1 primary Form 4 filing, an average of 0.5 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Sector
No other insider has filed at BridgeBio Pharma LLC's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Warren B. Kanders - $73.88M of CDRE open-market activity in the last 12 months
- Amirali Talasaz - $73.75M of GH open-market activity in the last 12 months
- James E. Flynn - $70.87M of NUVL open-market activity in the last 12 months
- Joaquin Duato - $66.84M of JNJ open-market activity in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $63.45M of SEPN open-market activity in the last 12 months
- BVF PARTNERS L P - $62.96M of MLTX open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
What is BridgeBio Pharma LLC?
BridgeBio Pharma LLC is a corporate entity of BridgeBio Oncology Therapeutics, Inc. (BBOT). InsiderAlpha holds 1 primary Form 4 filing for it, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did BridgeBio Pharma LLC last file a Form 4?
The only primary Form 4 on record is dated 10 October 2025.
Where can I see all of BridgeBio Pharma LLC's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow BridgeBio Pharma LLC and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial